Thyroid Carcinoma (DBCOND0032753)

Identifiers

Synonyms
Thyroid carcinoma / Carcinoma thyroid / Thyroid carcinoma NOS / Thyroid cancer / Malignant neoplasm of thyroid gland / Thyroid neoplasms malignant / Thyroid neoplasm malignant / Thyroid gland cancer / Malignant tumor of thyroid gland (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Iodide I-131
A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05786924
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive CancersNo drug interventionstreatment1active_not_recruiting
NCT02145143
Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot StudytreatmentNot Availableactive_not_recruiting
NCT06146764
CEUS Improves the Diagnostic Performance of SRSS of Thyroid CarcinomaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06439745
More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is EvaluatedNo drug interventionsNot AvailableNot Availablecompleted
NCT00749697
Radioiodine Dosimetry Protocol for Thyroid Cancer MetastasesNo drug interventionsdiagnosticNot Availableunknown_status
NCT01013597
Trial of LBH589 in Metastatic Thyroid Cancertreatment2completed
NCT04462471
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancerstreatment1completed
NCT01433809
Biomarkers to Distinguish Benign From Malignant Thyroid NeoplasmNo drug interventionsNot AvailableNot Availablecompleted
NCT01813136
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinomatreatment2completed
NCT00929318
Influence of Thyroid Hormones on the Woundhealing ProcessNo drug interventionsbasic_scienceNot Availableunknown_status
NCT02114658
Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patientstreatment2completed
NCT05178186
Impact of the COVID-19 Pandemic on Surgery for Thyroid CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT01487057
Lipid Metabolic Status in Thyroid CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT03500666
Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck DissectionNo drug interventionstreatmentNot Availableunknown_status
NCT02194920
Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT06270082
Study of IK-595 in RAS- or RAF-altered Advanced TumorsNo drug interventionstreatment1recruiting
NCT02185560
Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With SorafenibNot AvailableNot Availableactive_not_recruiting
NCT05668962
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCtreatment2recruiting
NCT06095362
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CWdiagnostic1completed
NCT00510640
Thyroid Cancer and Sunitinibtreatment2completed
NCT00647140
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid CancerNo drug interventionsdiagnostic2terminated
NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)treatment2recruiting
NCT02773667
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-IodineNo drug interventionsNot AvailableNot Availablecompleted
NCT02614495
Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinomatreatment2completed
NCT01865838
A Study Into the Effect of Seprafilm in Open Total ThyroidectomyNo drug interventionspreventionNot Availableterminated
NCT04666103
Function Integrity of Neck Anatomy in Thyroid SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT04411290
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00215605
Study of XL184 (Cabozantinib) in Adults With Advanced Malignanciestreatment1completed
NCT01707056
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid CarcinomaNo drug interventionstreatmentNot Availablewithdrawn
NCT00993837
Feasibility of Endoscopic Thyroidectomy for Thyroid CarcinomaNo drug interventionstreatmentNot Availableunknown_status
NCT04327999
Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct SystemNo drug interventionsprevention2terminated
NCT02658513
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05949424
OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adultstreatment4not_yet_recruiting
NCT03382158
International PPB/DICER1 RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03647358
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinomadiagnostic1recruiting
NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumorstreatment2recruiting
NCT01126060
Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Draintreatment3completed
NCT05796960
European Multicenter Study on Surgical Management of Advanced Thyroid CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03942380
Cell-free Tumor DNA in Head and Neck Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT04922801
Optimising Molecular Radionuclide TherapyNo drug interventionsNot AvailableNot Availablecompleted